Efficacy and Safety of Rituximab Second-Line Therapy for Membranous Nephropathy: A Prospective, Matched-Cohort StudyPaolo Cravedi, Piero Ruggenenti, Maria Chiara Sghirlanzoni et al.|American Journal of Nephrology|2011Cited by 71